A Stage-Based Approach to Therapy in Parkinson's Disease.

Parkinson’s disease acetylcholinesterase inhibitors amantadine anticholinergics dopamine-agonists l-dopa monoamine oxidase inhibitors motor symptoms non-motor symptoms non-pharmacological therapy

Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
20 08 2019
Historique:
received: 11 06 2019
revised: 31 07 2019
accepted: 14 08 2019
entrez: 23 8 2019
pubmed: 23 8 2019
medline: 23 6 2020
Statut: epublish

Résumé

Parkinson's disease (PD) is a neurodegenerative disorder that features progressive, disabling motor symptoms, such as bradykinesia, rigidity, and resting tremor. Nevertheless, some non-motor symptoms, including depression, REM sleep behavior disorder, and olfactive impairment, are even earlier features of PD. At later stages, apathy, impulse control disorder, neuropsychiatric disturbances, and cognitive impairment can present, and they often become a heavy burden for both patients and caregivers. Indeed, PD increasingly compromises activities of daily life, even though a high variability in clinical presentation can be observed among people affected. Nowadays, symptomatic drugs and non-pharmaceutical treatments represent the best therapeutic options to improve quality of life in PD patients. The aim of the present review is to provide a practical, stage-based guide to pharmacological management of both motor and non-motor symptoms of PD. Furthermore, warning about drug side effects, contraindications, as well as dosage and methods of administration, are highlighted here, to help the physician in yielding the best therapeutic strategies for each symptom and condition in patients with PD.

Identifiants

pubmed: 31434341
pii: biom9080388
doi: 10.3390/biom9080388
pmc: PMC6723065
pii:
doi:

Substances chimiques

Antiparkinson Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Ther Adv Neurol Disord. 2014 Jan;7(1):52-9
pubmed: 24409202
Neurology. 2017 Jul 4;89(1):88-100
pubmed: 28592453
Neurology. 2017 Oct 24;89(17):1795-1803
pubmed: 28954882
Mov Disord. 2015 Jan;30(1):90-102
pubmed: 25491470
Brain. 2015 Apr;138(Pt 4):963-73
pubmed: 25669730
Expert Rev Neurother. 2019 Feb;19(2):145-157
pubmed: 30570362
Postgrad Med J. 2001 Feb;77(904):89-93
pubmed: 11161073
Sleep. 1997 Sep;20(9):757-88
pubmed: 9406329
Hypertension. 2015 Jan;65(1):101-7
pubmed: 25350981
Sleep Med. 2003 Jul;4(4):281-4
pubmed: 14592300
JAMA. 2014 Apr 23-30;311(16):1670-83
pubmed: 24756517
Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006564
pubmed: 18425954
Acta Neuropathol Commun. 2016 Jun 30;4(1):66
pubmed: 27357212
Lancet Neurol. 2012 May;11(5):429-42
pubmed: 22516078
J Neural Transm (Vienna). 2018 Aug;125(8):1109-1117
pubmed: 29971495
Drugs. 2015 Dec;75(18):2065-71
pubmed: 26581672
Continuum (Minneap Minn). 2016 Aug;22(4 Movement Disorders):1064-85
pubmed: 27495198
J Neurol Neurosurg Psychiatry. 2002 Dec;73(6):636-42
pubmed: 12438462
J Neural Transm Suppl. 2000;(60):1-20
pubmed: 11205132
J Neurol Neurosurg Psychiatry. 2004 Jan;75(1):141-3
pubmed: 14707325
Mov Disord. 2008 Sep 15;23(12):1665-72
pubmed: 18709686
Cochrane Database Syst Rev. 2016 Jul 18;7:CD010916
pubmed: 27425786
Mov Disord. 2016 Apr;31(4):530-7
pubmed: 26817533
J Clin Sleep Med. 2010 Feb 15;6(1):85-95
pubmed: 20191945
Mov Disord. 2011 Aug 15;26(10):1814-24
pubmed: 21661055
J Neuropsychiatry Clin Neurosci. 1992 Summer;4(3):257-64
pubmed: 1498578
J Neural Transm (Vienna). 2004 Oct;111(10-11):1303-15
pubmed: 15480840
Dysphagia. 2015 Aug;30(4):452-6
pubmed: 25966655
Ther Adv Neurol Disord. 2009 Nov;2(6):29-41
pubmed: 21180628
Neuropsychopharmacology. 2010 Mar;35(4):881-92
pubmed: 19907417
J Neurol Neurosurg Psychiatry. 1992 Feb;55(2):138-42
pubmed: 1538221
Mov Disord. 2015 Jun;30(7):912-8
pubmed: 25914281
Neurology. 2004 Mar 23;62(6 Suppl 4):S3-7
pubmed: 15037664
Int J Geriatr Psychiatry. 2003 Nov;18(11):988-93
pubmed: 14618549
J Clin Invest. 1995 Jun;95(6):2458-64
pubmed: 7769091
Nat Rev Neurosci. 2017 Jan 20;18(2):101-113
pubmed: 28104909
Brain Res. 1989 Jan 2;476(1):154-9
pubmed: 2914210
Medicine (Baltimore). 2015 Apr;94(13):e649
pubmed: 25837755
Neurology. 1967 May;17(5):427-42
pubmed: 6067254
Mini Rev Med Chem. 2018;18(14):1168-1174
pubmed: 29692248
Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S219-23
pubmed: 20082995
Lancet. 2005 Mar 12-18;365(9463):947-54
pubmed: 15766996
Cochrane Database Syst Rev. 2012 Mar 14;(3):CD006504
pubmed: 22419314
Expert Opin Drug Saf. 2005 Jan;4(1):69-73
pubmed: 15709899
Lancet. 2014 Feb 8;383(9916):533-40
pubmed: 24183563
Mov Disord. 2006 Jun;21(6):737-45
pubmed: 16570299
Eur J Neurol. 2019 Jul;26(7):953-960
pubmed: 30681754
JAMA Neurol. 2013 Feb;70(2):183-90
pubmed: 23128427
N Engl J Med. 2013 Feb 14;368(7):610-22
pubmed: 23406026
Neurology. 2015 Jul 14;85(2):162-8
pubmed: 26085603
Acta Neurol Scand. 1976 May;53(5):376-85
pubmed: 1266576
Life Sci. 1988;43(3):255-62
pubmed: 3260986
Neurology. 2014 Nov 4;83(19):1739-46
pubmed: 25298306
J Clin Psychiatry. 2005 May;66(5):633-7
pubmed: 15889951
Neurobiol Dis. 2019 Dec;132:104462
pubmed: 31078682
Intern Med. 2016;55(3):231-6
pubmed: 26831015
Clin Auton Res. 2017 Jul;27(Suppl 1):29-31
pubmed: 28674867
JAMA. 2015 Feb 10;313(6):584-93
pubmed: 25668262
Clin Ther. 2005 Nov;27(11):1710-24
pubmed: 16368444
Mov Disord. 2005 Dec;20(12):1671; author reply 1671-2
pubmed: 16149099
Lancet Neurol. 2010 Nov;9(11):1106-17
pubmed: 20880751
J Neurol Sci. 2017 Aug 15;379:308-311
pubmed: 28716269
Nature. 1957 Nov 30;180(4596):1200
pubmed: 13483658
Ann Neurol. 1989 Aug;26(2):232-8
pubmed: 2774511
Lancet Neurol. 2006 Jul;5(7):572-7
pubmed: 16781987
J Neurol. 2019 Jul;266(7):1756-1770
pubmed: 31161388
Arch Neurol. 1989 Oct;46(10):1052-60
pubmed: 2508608
Sleep Med. 2017 Apr;32:16-21
pubmed: 28366329
Parkinsonism Relat Disord. 2013 Feb;19(2):153-7
pubmed: 22989561
Expert Rev Clin Pharmacol. 2017 Feb;10(2):131-151
pubmed: 28001447
Drugs. 2016 May;76(7):759-77
pubmed: 27091215
J Clin Neurosci. 2009 Feb;16(2):335-7
pubmed: 19056273
Molecules. 2019 Mar 01;24(5):
pubmed: 30823626
Mov Disord Clin Pract. 2018 Nov 08;5(6):627-634
pubmed: 30637284
J Neurochem. 2006 Sep;98(6):1866-75
pubmed: 16882311
Mov Disord. 2002 Sep;17(5):934-41
pubmed: 12360542
JAMA Psychiatry. 2015 May;72(5):438-45
pubmed: 25786075
Sci Rep. 2014 May 02;4:4874
pubmed: 24786396
Curr Neuropharmacol. 2016;14(3):260-71
pubmed: 26517052
Lancet Neurol. 2019 Feb;18(2):145-154
pubmed: 30663606
Int Rev Neurobiol. 2017;133:657-678
pubmed: 28802937
Clin Pharmacol Ther. 1992 May;51(5):541-8
pubmed: 1350237
Lancet Neurol. 2014 Feb;13(2):141-9
pubmed: 24361112
PLoS One. 2010 Dec 31;5(12):e15298
pubmed: 21217832
Neurology. 2003 Nov 25;61(10):1418-20
pubmed: 14638967
Arch Neurol. 2000 Feb;57(2):263-7
pubmed: 10681087
J Neurochem. 1990 Oct;55(4):1454-6
pubmed: 1697897
Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
pubmed: 12498954
Cochrane Database Syst Rev. 2012 Jan 18;1:CD005429
pubmed: 22258963
Mov Disord. 2017 Feb;32(2):211-218
pubmed: 27886407
Mov Disord. 2013 Jul;28(8):1138-41
pubmed: 23483627
Neurology. 1999 Sep 22;53(5):1012-9
pubmed: 10496260
Am J Geriatr Pharmacother. 2010 Aug;8(4):316-30
pubmed: 20869621
Medicine (Baltimore). 2015 Jul;94(28):e1118
pubmed: 26181547
Prog Neurobiol. 2017 Apr;151:57-100
pubmed: 27389773
N Engl J Med. 2007 Jan 4;356(1):39-46
pubmed: 17202454
J Neurol Sci. 2011 Nov 15;310(1-2):36-9
pubmed: 21762926
Neurology. 2005 Apr 12;64(7):1162-9
pubmed: 15824341
Mol Ther Nucleic Acids. 2017 Sep 15;8:508-519
pubmed: 28918051
Yale J Biol Med. 2016 Mar 24;89(1):37-47
pubmed: 27505015
J Neurol Neurosurg Psychiatry. 1997 May;62(5):436-46
pubmed: 9153598
Eur J Neurol. 2010 Mar;17(3):364-76
pubmed: 20050885
Expert Opin Pharmacother. 2017 Mar;18(4):445-453
pubmed: 28234566
Neurology. 2002 Dec 10;59(11):1708-13
pubmed: 12473757
Mov Disord. 2016 Jul;31(7):1054-8
pubmed: 27214258
Mov Disord. 1991;6(2):151-6
pubmed: 2057006
Neurology. 2014 Jul 29;83(5):413-25
pubmed: 24991037
Front Neurol. 2018 May 22;9:330
pubmed: 29872418
J Neurol Neurosurg Psychiatry. 2007 May;78(5):476-9
pubmed: 17098844
Curr Opin Neurol. 2016 Aug;29(4):474-9
pubmed: 27272976
Eur J Neurol. 2011 Jan;18(1):5-18
pubmed: 20482602
NPJ Parkinsons Dis. 2018 Mar 16;4:6
pubmed: 29560414
Lancet. 2018 Apr 7;391(10128):1357-1366
pubmed: 29477251
J Neurol Neurosurg Psychiatry. 2013 Feb;84(2):130-5
pubmed: 22933817
Neurology. 2015 Feb 17;84(7):654-8
pubmed: 25609758
Mov Disord. 2015 Oct;30(12):1600-11
pubmed: 26474317
Clin Neurol Neurosurg. 2005 Jun;107(4):306-9
pubmed: 15885389
Drugs. 2019 Apr;79(6):593-608
pubmed: 30905034
J Clin Psychopharmacol. 2012 Oct;32(5):732-4
pubmed: 22926620
J Neurol Neurosurg Psychiatry. 2019 Jan;90(1):2
pubmed: 30361297
Brain. 2007 Nov;130(Pt 11):2770-88
pubmed: 17412731
N Engl J Med. 2010 Jun 3;362(22):2077-91
pubmed: 20519680
Int Urol Nephrol. 2012 Apr;44(2):415-24
pubmed: 21553114
Cochrane Database Syst Rev. 2001;(2):CD002812
pubmed: 11406044
Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S123-7
pubmed: 24262162
Mov Disord. 2015 Oct;30(12):1591-601
pubmed: 26474316
N Engl J Med. 1997 Jan 16;336(3):186-95
pubmed: 8988899
Brain Res. 1982 May 6;239(1):81-105
pubmed: 7093693
Acta Neurol Scand. 2006 Jan;113(1):1-8
pubmed: 16367891
Lancet. 2015 Aug 29;386(9996):896-912
pubmed: 25904081
Ann Neurol. 1996 Jul;40(1):99-107
pubmed: 8687199
Lancet Neurol. 2006 Oct;5(10):864-72
pubmed: 16987733
Lancet. 1991 Oct 19;338(8773):1022-3
pubmed: 1681331
J Mov Disord. 2019 Jan;12(1):37-42
pubmed: 30732431
Ann Agric Environ Med. 2019 Mar 22;26(1):133-137
pubmed: 30922043
J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):368-76
pubmed: 18344392
Clin Neuropharmacol. 2009 May-Jun;32(3):158-9
pubmed: 19483483
Mov Disord. 2018 Apr;33(4):642-646
pubmed: 29436740
Mov Disord. 2015 Sep;30(10):1417-21
pubmed: 26208108
Parkinsonism Relat Disord. 2011 Mar;17(3):156-9
pubmed: 21193343
Mov Disord. 1994 Jul;9(4):431-6
pubmed: 7969210
Arch Neurol. 1999 May;56(5):529-35
pubmed: 10328247
Am J Med. 1996 Mar;100(3):333-7
pubmed: 8629680
Eur J Neurol. 2016 Jan;23(1):30-8
pubmed: 26423203
CNS Drugs. 2008;22(6):519-27
pubmed: 18484793
Neuropsychiatr Dis Treat. 2017 May 16;13:1313-1330
pubmed: 28553118
BMJ. 2004 Sep 11;329(7466):593
pubmed: 15310558
Mov Disord. 2019 Feb;34(2):180-198
pubmed: 30653247
Cochrane Database Syst Rev. 2003;(1):CD003468
pubmed: 12535476
Dysphagia. 2016 Feb;31(1):24-32
pubmed: 26590572
Mov Disord. 2011 Feb 15;26(3):416-23
pubmed: 21264942
JAMA Neurol. 2017 Feb 1;74(2):197-206
pubmed: 28027332
Mov Disord. 2011 Oct;26 Suppl 3:S42-80
pubmed: 22021174
N Engl J Med. 2006 Aug 31;355(9):896-908
pubmed: 16943402
Br Med Bull. 2008;86:109-27
pubmed: 18398010
Mov Disord. 2012 Apr 15;27(5):617-26
pubmed: 22508280
Aust Prescr. 2019 Apr;42(2):78-79
pubmed: 31048946
Neurology. 2009 Nov 24;73(21):1752-8
pubmed: 19933976
Mov Disord. 2015 Jan;30(1):80-9
pubmed: 25488260
Brain. 2002 Nov;125(Pt 11):2431-45
pubmed: 12390970
Mov Disord. 2018 May;33(5):660-677
pubmed: 29644751
J Neural Transm Suppl. 1995;46:399-405
pubmed: 8821075
Parkinsonism Relat Disord. 2009 Dec;15 Suppl 4:S97-100
pubmed: 20123567
Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15222-7
pubmed: 10611366
Parkinsonism Relat Disord. 2011 Nov;17(9):662-6
pubmed: 21705259
Curr Psychiatry Rep. 2016 Oct;18(10):97
pubmed: 27629356
Acta Neurol Scand. 2018 Dec;138(6):508-514
pubmed: 30058142
Cell Transplant. 1997 May-Jun;6(3):309-15
pubmed: 9171163
Expert Rev Neurother. 2015 May;15(5):549-62
pubmed: 25936847
Nat Rev Neurol. 2012 May 15;8(6):329-39
pubmed: 22584158
J Neurol Sci. 2017 Mar 15;374:53-55
pubmed: 28104232
J Parkinsons Dis. 2016 Oct 19;6(4):787-792
pubmed: 27662329
Parkinsons Dis. 2018 Dec 2;2018:8104673
pubmed: 30631420
Int J Geriatr Psychiatry. 2010 Oct;25(10):1030-8
pubmed: 20872929
Neurology. 1995 Jul;45(7):1305-8
pubmed: 7617188
J Clin Pharm Ther. 2014 Oct;39(5):564-6
pubmed: 24845114
Acta Neurol Scand. 2013 Apr;127(4):290-4
pubmed: 22998158
J Parkinsons Dis. 2011;1(2):197-203
pubmed: 23934921
J Neuropsychiatry Clin Neurosci. 2017 Winter;29(1):22-25
pubmed: 27829318
Mov Disord. 2016 May;31(5):709-14
pubmed: 27030249
Clin Neuropharmacol. 1995 Aug;18(4):338-47
pubmed: 8665547
J Neurol Neurosurg Psychiatry. 2014 Jun;85(6):668-74
pubmed: 24218528
Sleep Med. 2013 Mar;14(3):237-42
pubmed: 23352028
JAMA Neurol. 2017 Aug 1;74(8):941-949
pubmed: 28604926
Dysphagia. 2008 Mar;23(1):76-81
pubmed: 17602261
Parkinsonism Relat Disord. 2019 Jul;64:175-180
pubmed: 30992235
Mov Disord. 2007 Jun 15;22(8):1061-8
pubmed: 17266092
Expert Opin Pharmacother. 2019 Feb;20(2):219-230
pubmed: 30411647
Lancet. 2017 Oct 7;390(10103):1664-1675
pubmed: 28781108
Neurology. 2004 Aug 24;63(4):746-8
pubmed: 15326260
J Neural Transm (Vienna). 2008;115(3):443-60
pubmed: 18327532
CNS Drugs. 2016 Nov;30(11):1079-1095
pubmed: 27743318
Parkinsonism Relat Disord. 2015 Feb;21(2):120-5
pubmed: 25483722
Mov Disord. 2001 May;16(3):515-20
pubmed: 11391748
Mov Disord. 1993 Apr;8(2):165-70
pubmed: 8474483
Eur J Neurol. 2009 Dec;16(12):1305-11
pubmed: 19570145
Mov Disord. 2014 Jul;29(8):1064-9
pubmed: 24789677
Expert Rev Neurother. 2019 Apr;19(4):293-299
pubmed: 30892103
Electroencephalogr Clin Neurophysiol. 1988 Nov-Dec;71(6):461-8
pubmed: 2460327
Lancet Neurol. 2016 Mar;15(3):249-58
pubmed: 26795874
Drugs. 2018 Jun;78(8):833-844
pubmed: 29869204
Parkinsonism Relat Disord. 2019 Oct;67:74-89
pubmed: 31272925
Mov Disord. 2011 Aug 15;26(10):1851-8
pubmed: 21500280
J Sleep Res. 2010 Dec;19(4):591-6
pubmed: 20561180
J Neurochem. 2016 Oct;139 Suppl 1:318-324
pubmed: 27401947
Parkinsonism Relat Disord. 2016 Feb;23:17-22
pubmed: 26709292
J Parkinsons Dis. 2016 Oct 19;6(4):685-698
pubmed: 27567884
J Parkinsons Dis. 2017;7(4):545-568
pubmed: 29036837
Mov Disord. 2011 Feb 1;26(2):264-70
pubmed: 21412833
Brain. 2000 Feb;123 ( Pt 2):331-9
pubmed: 10648440
Parkinsonism Relat Disord. 2010 Jan;16(1):16-20
pubmed: 19616987
Psychiatry Clin Neurosci. 2001 Jun;55(3):267-9
pubmed: 11422870
Acta Neuropathol. 2007 Apr;113(4):421-9
pubmed: 17294202
Restor Neurol Neurosci. 2015;33(4):521-30
pubmed: 26409410
BJU Int. 2015 Jan;115(1):32-40
pubmed: 24602031
Neurosci Biobehav Rev. 2015 Oct;57:105-17
pubmed: 26297812
N Engl J Med. 2009 Sep 24;361(13):1268-78
pubmed: 19776408
Schizophr Res. 2002 Jul 1;56(1-2):1-10
pubmed: 12084413
Curr Opin Neurol. 2013 Aug;26(4):374-80
pubmed: 23817213
Mov Disord. 2011 Jul;26(8):1552-5
pubmed: 21538524
Parkinsonism Relat Disord. 2018 Jul;52:7-16
pubmed: 29550375
Sleep. 2008 Oct;31(10):1418-21
pubmed: 18853939
Neuropsychiatr Dis Treat. 2017 Mar 08;13:737-744
pubmed: 28331324
J Neurol Neurosurg Psychiatry. 2015 Jul;86(7):767-73
pubmed: 25224676
Pract Neurol. 2015 Apr;15(2):100-4
pubmed: 25489118
Mov Disord. 2008 Jun 15;23(8):1130-6
pubmed: 18442107
Mov Disord. 2014 Feb;29(2):229-37
pubmed: 24323641
Neuroreport. 2004 Dec 3;15(17):2621-4
pubmed: 15570164
Medicine (Baltimore). 2015 Jan;94(4):e411
pubmed: 25634170
J Neurol Sci. 2018 Oct 15;393:63-68
pubmed: 30118919
J Sleep Res. 1993 Dec;2(4):224-231
pubmed: 10607098
Nat Rev Neurol. 2019 Apr;15(4):204-223
pubmed: 30867588
Semin Neurol. 2017 Apr;37(2):147-157
pubmed: 28511255
Mov Disord. 2018 Aug;33(8):1248-1266
pubmed: 29570866
Mov Disord. 2018 Mar;33(3):372-390
pubmed: 29508455
Eur J Neurol. 2013 Jan;20(1):5-15
pubmed: 23279439
Mov Disord. 2015 Jan;30(1):64-72
pubmed: 25449210
Drug Discov Today. 2016 May;21(5):802-18
pubmed: 26851597
Nat Rev Neurol. 2017 Nov;13(11):689-703
pubmed: 29027544
Arch Neurol. 2010 Jan;67(1):58-63
pubmed: 20065130
Neurology. 1986 Aug;36(8):1130-3
pubmed: 3736883
Brain. 2014 May;137(Pt 5):1481-95
pubmed: 24574503
Am J Psychiatry. 2011 Oct;168(10):1066-74
pubmed: 21676990
Curr Opin Otolaryngol Head Neck Surg. 2015 Jun;23(3):209-15
pubmed: 25943966
Neurodegener Dis Manag. 2016 Jun;6(3):249-68
pubmed: 27230697
Brain. 2013 Jul;136(Pt 7):2098-108
pubmed: 23757762
J Neurosci. 2013 Jul 17;33(29):11986-93
pubmed: 23864685
Mov Disord. 2014 Nov;29(13):1615-22
pubmed: 24821648
Neurology. 2004 Jan 13;62(1 Suppl 1):S17-30
pubmed: 14718677
Ann Neurol. 1994 Dec;36(6):876-81
pubmed: 7998774
Brain Stimul. 2015 Nov-Dec;8(6):1223-5
pubmed: 26319357
Trends Neurosci. 2006 Nov;29(11):647-54
pubmed: 17030429
Lancet Neurol. 2010 Oct;9(10):969-77
pubmed: 20729148
Neurology. 2010 Oct 5;75(14):1263-9
pubmed: 20810998
JAMA Neurol. 2014 May;71(5):543-52
pubmed: 24664227

Auteurs

Claudia Carrarini (C)

Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, 66100 Chieti, Italy.

Mirella Russo (M)

Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, 66100 Chieti, Italy.

Fedele Dono (F)

Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, 66100 Chieti, Italy.

Martina Di Pietro (M)

Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, 66100 Chieti, Italy.

Marianna G Rispoli (MG)

Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, 66100 Chieti, Italy.

Vincenzo Di Stefano (V)

Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, 66100 Chieti, Italy.

Laura Ferri (L)

Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, 66100 Chieti, Italy.

Filomena Barbone (F)

Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, 66100 Chieti, Italy.

Michela Vitale (M)

Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, 66100 Chieti, Italy.

Astrid Thomas (A)

Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, 66100 Chieti, Italy.

Stefano Luca Sensi (SL)

Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, 66100 Chieti, Italy.

Marco Onofrj (M)

Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, 66100 Chieti, Italy.

Laura Bonanni (L)

Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, 66100 Chieti, Italy. l.bonanni@unich.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH